{"abstract":"The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, on behalf of the Centers for Disease Control and Prevention, Department of Health and Human Services, is contemplating the grant of an exclusive patent commercialization license to Becton, Dickinson and Company, located in Franklin Lakes, New Jersey, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2017/11/16/2017-24774.html","cfr_references":[],"citation":"82 FR 53512","comment_url":null,"comments_close_on":"2017-12-01","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases on or before December 1, 2017 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2017-24774","effective_on":null,"end_page":53513,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2017/11/16/2017-24774.xml","html_url":"https://www.federalregister.gov/documents/2017/11/16/2017-24774/prospective-grant-of-exclusive-patent-commercialization-license-direct-reading-detection-kits-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2017-24774?publication_date=2017-11-16","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2017-11-16/2017-24774/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":112,"last_updated":"2026-08-25 02:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2017-11-16/pdf/2017-24774.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2017-24774.pdf?1510753538","publication_date":"2017-11-16","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2017/11/16/2017-24774.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T20:16:09Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":53512,"subtype":null,"title":"Prospective Grant of Exclusive Patent Commercialization License: Direct Reading Detection Kits for Surface Contamination by Antineoplastic Drugs","toc_doc":"Direct Reading Detection Kits for Surface Contamination by Antineoplastic Drugs","toc_subject":"Prospective Grant of Exclusive Patent Licenses:","topics":[],"type":"Notice","volume":82}